Login
Toggle navigation
Videos
Categories
Trending
A Financial Analyst at SilverStone Group, Inc., holding a Chemistry bachelor's degree and an MBA from Creighton University.
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Karan Keith Agarwal - Founder | CEO - Silverstone Group
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
Geregu Power and Siemens sign agreement aimed at enhancing power generation capabilities, as mentioned by General Electric Company's Chairman and CEO, Immelt, at The Economic Club.
00:00:00
Stefan Weber, CEO, Newron Pharmaceuticals
00:10:00
Ideas to Innovations of Adeia Inc | Paul Davis, CEO, Adeia IncADEA:NSQ
00:10:00
Ucore Receives $4M Grant from US Department of Defense
00:10:00
Investor Jenny Harrington is buying shares of Clearway Energy due to favorable valuation and growth prospects at current levels.
00:10:00
Ex-Hyflux CEO Olivia Lum and ex-CFO, along with four others, charged in court amid corporate governance issues.
00:10:00
Steve Adubato and Mary Gamba discuss with Larry Downes the critical role of continuous learning in personal and professional growth.
00:10:00
Investor Interest Amid Geopolitical and Economic Challenges in Greece's Energy Transition and Water Sector | Mr. Harry Sachinis, CEO, Athens Water Supply & Sewerage Company SA.
00:10:00
De Belegger on Tour - Pitch with Francis Van Eeckhout, CEO Deceuninck | Francis Van Eeckhout - CEO of Deceuninck
00:10:00
Understanding Just Transition in Energy Policy: Global Insights and Implications
00:10:00
From Farm Dreams to Language Learning: The Growth Journey of Duolingo with Gina Gotthilf|Gina Gotthilf,VP,Duolingo
00:10:00
Boosting Employee Engagement: Key to Organizational Success